ASCO 2022 Updates in HR+/HER2- eBC


 

ASCO 2022 Optimization of the Duration of Adjuvant Endocrine Therapy in Early Breast Cancer

28 views
June 13, 2022
0 Comments
Login to view comments. Click here to Login
ASCO 2022 Updates in HR+/HER2- eBC